Skip to content
healthcare.dev

Glipizide

NDC 51655-106, Glipizide, tablet, from Northwind Health Company, LLC.

Product NDC
51655-106
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075795
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-106 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIPIZIDE10 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
51655-106-255165501062560 TABLET in 1 BOTTLE, DISPENSING (51655-106-25)
51655-106-265165501062690 TABLET in 1 BOTTLE, DISPENSING (51655-106-26)
51655-106-525165501065230 TABLET in 1 BOTTLE, DISPENSING (51655-106-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0ed5ed22-dd53-495d-bc10-0bede4d87926

Use it

Look up 51655-106 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-106 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.